Open-label trial of recombinant human insulin-like growth factor 1/recombinant human insulin-like growth factor binding protein 3 in myotonic dystrophy type 1
Chad R. Heatwole, Katy J. Eichinger, Deborah I Friedman, James E. Hilbert, Carlayne E. Jackson, Eric L. Logigian, William B. Martens, Michael P. McDermott, Shree K. Pandya, Christine Quinn, Alexis M. Smirnow, Charles A. Thornton, Richard T. Moxley
Dive into the research topics of 'Open-label trial of recombinant human insulin-like growth factor 1/recombinant human insulin-like growth factor binding protein 3 in myotonic dystrophy type 1'. Together they form a unique fingerprint.